2005
DOI: 10.2174/0929867054039053
|View full text |Cite
|
Sign up to set email alerts
|

Structural Requirements for Binding of Myelin Basic Protein (MBP) Peptides to MHC II: Effects on Immune Regulation

Abstract: Confronting Multiple Sclerosis requires as an underlying step the manipulation of immune response through modification of Myelin Basic Protein peptides. The aim is to design peptidic or nonpeptidic molecules that compete for recognition of self-antigens at the level of antigen presentation. The rational approach is to substitute residues that serve as anchors for the T-Cell Receptor with others that show no binding at all, and those that serve as Major Histocompatibility Complex II anchors with others that pre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
38
0

Year Published

2006
2006
2015
2015

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(39 citation statements)
references
References 68 publications
(141 reference statements)
1
38
0
Order By: Relevance
“…This may also explain their antagonistic versus agonistic activity. Such differences in the binding motifs between linear and cyclic agonists and antagonists analogues of MBP 87-99 epitope were also shown in our previous work [19][20][21][22][23][24][25][26].…”
Section: Resultssupporting
confidence: 83%
See 1 more Smart Citation
“…This may also explain their antagonistic versus agonistic activity. Such differences in the binding motifs between linear and cyclic agonists and antagonists analogues of MBP 87-99 epitope were also shown in our previous work [19][20][21][22][23][24][25][26].…”
Section: Resultssupporting
confidence: 83%
“…NMR spectroscopy is coupled with MD simulations to study the binding motif of the altered peptide epitopes of MBP 83-99 with HLA-DR2 [19][20][21][22][23][24][25][26][27][28][29][30][31].…”
Section: Introductionmentioning
confidence: 99%
“…One of the candidate autoantigens in MS is MBP, because of its early identification as an agent that can induce EAE in a susceptible host [235]. The cerebrospinal fluid of patients with MS contains both MBP-derived peptides [236] and elevated levels of autoantibodies to MBP [237][238][239][240][241][242][243], inspiring strategies for MS immunotherapy by injection of synthetic MBP peptides [243][244][245][246].…”
Section: Effects Of Deimination-mbp Immunogenicitymentioning
confidence: 99%
“…Moreover, the intramolecular hydrogen bonds between the Gln 3 and Arg 5 (Fig. 7) for the [20,[26][27][28][29][30].…”
Section: Resultsmentioning
confidence: 99%